Gregory Gosch has been named vice president of marketing for Luminex. Before joining Luminex, Gosch served as senor director of sales and marketing for Nanogen, headquartered in San Diego. He has also held marketing and product-management positions for Chiron and Bio-Rad Laboratories.
Millipore said last week that it has appointed Martin Madaus as president and CEO, effective no later than Feb. 1, 2005. Maduas will replace Francis Lunger, who will remain as chairman of the board during the transition. Maduas will also join Millipore’s board of directors, the company said.
Maduas joins Millipore from Roche Diagnostics, where he was president and CEO, Millipore said. Prior to his appointment as president and CEO in 2000, Maduas was vice president of business development at Roche Diagnostics. He has also held positions at Boehringer Mannheim, which was acquired by Roche in 1998. Maduas holds a PhD in veterinary medicine.
Kevin Farr has been elected to the board of directors of Beckman Coulter, effective Oct. 8, the company said last week. He is the chief financial officer for Mattel. Farr holds an MBA from Northwestern University and a bachelor’s degree from Michigan State University.
Michael Schrader, the co-founder and chief technology officer of BioVisioN is planning to move back to academia, according to a statement released last week. He has been appointed to a professorship in physical chemistry and instrumental analysis at the Department of Biotechnology and Bioinformatics at the University of Applied Sciences Weihenstephan in Freising, Germany.
“This is an excellent opportunity to harvest ten years of experience in the jump-started German biotech scene by teaching young engineers the skills necessary for working in this type of industry,” said Scrader.